Adjust portions, foods, and timing based on your individual needs and tolerances
Patients who combine GLP-1 medications with resistance training preserve significantly more muscle than those relying on diet and medication alone
Among women with PCOS, semaglutide or tirzepatide prescribing increased from 2.4% in 2021 to 17.6% in 2025, a more than 7-fold increase
Tirzepatide demonstrated larger initial incremental effects at lower doses, whereas semaglutide showed continued incremental benefit across an extended dose range
Common factors include stress, changes in weight, excessive exercise, illness, travel, and hormonal imbalances such as thyroid disorders or polycystic ovary syndrome (PCOS)